Literature DB >> 24854612

A randomized controlled trial of home monitoring versus hospitalization for mild non-alcoholic acute interstitial pancreatitis: a pilot study.

Ali Tüzün Ince1, Hakan Senturk2, Vikesh K Singh3, Kemal Yildiz1, Ahmet Danalioğlu1, Ahmet Cinar1, Omer Uysal1, Orhan Kocaman1, Birol Baysal1, Ahmet Gürakar3.   

Abstract

BACKGROUND/
OBJECTIVES: Acute pancreatitis (AP) is a disease typically requiring in-hospital treatment. We conducted a trial to assess the feasibility of early discharge from the hospital for patients with mild non-alcoholic acute pancreatitis (NAAP).
METHODS: Eighty-four patients with mild NAAP were randomized to home or hospital groups after a short hospital stay (≤24 h). AP was defined by the revised Atlanta criteria. Mild AP was defined as an Imrie score≤5 and a harmless acute pancreatitis score (HAPS)≤2 in the first 24-h of presentation. A nurse visited all patients in the home group on the 2nd, 3rd and 5th days. All patients presented for follow-up in clinic on the 7th, 14th, and 30th days. The primary outcome was the time to resolution of pain. Secondary outcomes evaluated included time to resumption of an oral diet, 30 day hospital readmission rate as well as the total costs associated with either approach to care.
RESULTS: There was no difference between the groups with regards to demographics, prognostic severity scores, symptoms, and biliary findings. No patients developed organ failure, pancreatic necrosis, or died in either group. Time to the resolution of pain and resumption of solid food intake were similar. Three (3.6%) patients required readmission within 30 days, 1 from home and 2 from the hospital groups. The total cost was significantly less in home group ($139 ± 73 vs. $951 ± 715,p < 0.001).
CONCLUSIONS: Mild NAAP can be safely treated at home with regular visits by a nurse under the supervision of a physician. Widespread adoption of this practice may result in large cost savings.
Copyright © 2014 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute interstitial pancreatitis; Home monitoring; Home therapy; Mild acute pancreatitis

Mesh:

Year:  2014        PMID: 24854612     DOI: 10.1016/j.pan.2014.02.007

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  6 in total

1.  Prediction of Self-Limited Acute Pancreatitis Cases at Admission to Emergency Unit.

Authors:  Yusuf Kayar; Hakan Senturk; Mukaddes Tozlu; Birol Baysal; Musa Atay; Ali Tuzun Ince
Journal:  GE Port J Gastroenterol       Date:  2018-11-14

Review 2.  Early discharge hospital at home.

Authors:  Daniela C Gonçalves-Bradley; Steve Iliffe; Helen A Doll; Joanna Broad; John Gladman; Peter Langhorne; Suzanne H Richards; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2017-06-26

3.  Morphologic Severity of Acute Pancreatitis on Imaging Is Independently Associated with Opioid Dose Requirements in Hospitalized Patients.

Authors:  Aditya Ashok; Mahya Faghih; Elham Afghani; Javad R Azadi; Nasim Parsa; Christopher Fan; Furqan Bhullar; Francisco G Gonzalez; Niloofar Y Jalaly; Tina Boortalary; Mouen A Khashab; Ayesha Kamal; Venkata S Akshintala; Atif Zaheer; Vikesh K Singh
Journal:  Dig Dis Sci       Date:  2021-04-09       Impact factor: 3.487

4.  Detection of Common Bile Duct Stones in Mild Acute Biliary Pancreatitis Using Magnetic Resonance Cholangiopancreatography.

Authors:  David Aranovich; Veacheslav Zilbermints; Natalia Goldberg; Oleg Kaminsky
Journal:  Surg Res Pract       Date:  2018-10-22

5.  Use of Modified Balthazar Grades for the Early Prediction of Acute Pancreatitis Severity in the Emergency Department.

Authors:  Tao Cheng; Tian-Yong Han; Bo-Fu Liu; Pan Pan; Qiang Lai; Haifang Yu; Yu Cao
Journal:  Int J Gen Med       Date:  2022-02-04

6.  A Rapid Prognostic Score Based on Bedside Arterial Blood Gas Analysis (ABG) Established for Predicting 60-Day Adverse Outcomes in Patients with Acute Pancreatitis in the Emergency Department.

Authors:  Qiang Lai; Wei Wei; Yarong He; Tao Cheng; Tianyong Han; Yu Cao
Journal:  J Inflamm Res       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.